Manufacture/distributor BR-PH
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2D222D0145
- Awardee
-
Mylan Pharmaceuticals Inc. UEI NDN1MYB8DKK5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Task orders
- 0
Award facts
- Opportunity
-
- Estradiol Patch 24H Pre-Solicitation · SPE2D221R0115 · Posted Sep 30, 2021
- Last date to order 84% complete
- IDV ceiling
- $9,549,893.15
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This single-award Indefinite Delivery Contract, valued at $9.55 million with an ultimate completion date of August 25, 2027, was awarded by the Defense Logistics Agency's Medical Supply Chain division to Mylan Pharmaceuticals Inc. on August 26, 2022. The contract encompasses the manufacture and distribution of pharmaceutical products classified under the Federal Supply Classification code 4610093699. As the prime contractor, Mylan Pharmaceuticals Inc. (UEI: NDN1MYB8DKK5), a registered for-profit pharmaceutical manufacturer with federal contracting history dating to October 2003, will serve as the exclusive supplier under this no-set-aside vehicle. The originating solicitation was issued as a pre-solicitation notice on September 30, 2021, establishing the foundation for this competitive acquisition.
Under this contract, Mylan will supply specialty pharmaceutical products to federal healthcare beneficiaries across multiple agencies, including the Department of Veterans Affairs, Department of Defense, Federal Bureau of Prisons, and Indian Health Service. Based on Mylan's historical delivery performance under similar Defense Logistics Agency contracts and the Medical Supply Chain designation, the products likely include transdermal patches and specialty medications for chronic conditions such as Alzheimer's disease, Parkinson's disease, and women's health applications. The indefinite delivery structure establishes a five-year procurement relationship with an estimated annual demand exceeding 19,000 units, enabling streamlined distribution of critical pharmaceutical supplies to federal medical facilities nationwide. The contract ceiling of $9.55 million provides budgetary authority for delivery orders issued throughout the performance period.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract SPE2D222D0145?
SPE2D222D0145 was awarded to Mylan Pharmaceuticals Inc. by Medical Supply Chain (Troop Support) on August 26, 2022.
How much is contract SPE2D222D0145 worth?
SPE2D222D0145's own ceiling is $9,549,893.
Who can order from contract SPE2D222D0145?
SPE2D222D0145 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2D222D0145 competed?
The extent of competition for SPE2D222D0145 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV